Abstract
Objective: To develop and validate a risk prediction and stratification model in patients with the diagnosis of Pneumonia due to SARS-CoV-2. Material and method: Cohort study, observational and single-center, which included patients who came to the hospital emergency room with suspected COVID-19 pneumonia. Data from the patients at admission were analyzed: age, gender, existence and number of comorbidities, as well as analytical data and respiratory rate, oxygen saturation, Glasgow scale. Results: The model has included 15 variables, which with their corresponding weighting have shown a high discrimination capacity both in development (C statistic 0.823, 95% confidence interval) and in its validation (C statistic 0.794, 95% confidence interval). Conclusions: The model has shown a high capacity for discrimination and stratification of clinical risk in 3 levels (low, medium or high) of the patients.
| Translated title of the contribution | Development and validation of a risk stratification model in patients with SARS-CoV-2 pneumonia (Covid Cruces) |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 3-11 |
| Number of pages | 9 |
| Journal | Gaceta Medica de Bilbao |
| Volume | 119 |
| Issue number | 1 |
| State | Published - 2022 |
Keywords
- COVID-19
- Cruces Model
- Pandemic
Fingerprint
Dive into the research topics of 'Development and validation of a risk stratification model in patients with SARS-CoV-2 pneumonia (Covid Cruces)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver